Nutraceuticals · Chile, Patagonia, Japan, global screen-heavy markets
Maqui berry extract gives eye-health brands a consumer-ready read around tear production, eye fatigue, screen use, and anthocyanin-rich daily support.
The market story in plain English.
Maqui berry is one of the more consumer-ready reads because the need is obvious: dry eyes, eye fatigue, screen exposure, and daily visual strain. The ingredient already has clinical positioning around tear production and eye comfort, but the larger category opportunity is screen-era eye hydration as a routine wellness product.
The first products are likely capsules, gummies, sachets, and eye-health bundles paired with lutein-like positioning, omega oils, or workplace wellness programs. The buyer is a screen-heavy consumer, gamer, office worker, older adult, or contact-lens user who wants something more proactive than occasional eye drops.
Japan is a natural early market because standardized maqui eye-health products have already had traction there. Chile gives the ingredient its origin story, while the U.S., South Korea, and pharmacy channels offer scale. The positioning has to stay grounded in comfort and hydration rather than broad vision claims.
The companies to watch are standardized extract suppliers, eye-health brands, pharmacy private labels, and workplace wellness companies. The read strengthens when maqui moves from niche eye supplement into a broader screen-fatigue category with simple daily-use language.
The first buyers, builders, and channels likely to care.
Eye-health supplement brands, workplace wellness companies, screen-fatigue product makers, pharmacy channels, and beauty-wellness brands.
Likely early markets and channel fit.
Japan, South Korea, U.S. pharmacy and online wellness, Chilean supply chains, and screen-heavy office or gaming consumers.
The kinds of organizations that can turn the read into a market.
Standardized maqui extract suppliers, eye-health brands, workplace wellness companies, pharmacy private labels, and screen-fatigue product makers.
Signals that would make the read more concrete.
Watch for newer trials, pharmacy adoption, gaming or workplace wellness bundles, stronger dose clarity, and repeat-purchase behavior.